1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > United States – Biopsy Testing Market & Volume Analysis to 2020

United States – Biopsy Testing Market – Overview

United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing type of cancer in the United States. However if we make the analysis from the Volume point then Prostate Cancer is the most popular segment. Increasing United States prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period.

Renub Research report titled “United States – Biopsy Testing Market & Volume Analysis to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Biopsy Market. This 53 page report with 28 Figures and 1 Table analyses the United States Biopsy Test Market and Volume by 5 Top Cancer Segment, driving factors and challenges for Biopsy market.

The United States Biopsy Market has been analyzed from two view points

- United States Biopy Test Market & Forecast (2008 – 2020)
- United States Biopy Test Volume & Forecast (2008 – 2020)


The Top 5 Cancer Segments covered are:

1. Breast Cancer
2. Prostate Cancer
3. Liver Cancer
4. Lung Cancer
5. Thyroid Cancer



Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table Of Contents

United States - Biopsy Testing Market and Volume Analysis to 2020
Table of Contents

1. Executive Summary

2. United States Biopsy Test Market, Volume and Forecast (2008 - 2020)
2.1 United States Biopsy Test Market and Forecast
2.2 United States Biopsy Test Volume and Forecast

3. United States Biopsy Test Market and Volume Share Analysis (2008 - 2020)
3.1 United States Biopsy Test Market Share and Forecast
3.2 United States Biopsy Test Volume Share and Forecast

4. United States Biopsy Market and Volume Forecast - Test Segment Analysis (2008 - 2020)
4.1 United States - Prostate Cancer Biopsy Test Market and Volume Forecast
4.1.1 United States - Prostate Cancer Biopsy Test Market and Forecast
4.1.2 United States - Prostate Cancer Biopsy Test Volume and Forecast

4.2 United States - Breast Cancer Biopsy Test Market and Volume Forecast
4.2.1 United States - Breast Cancer Biopsy Test Market and Forecast
4.2.2 United States - Breast Cancer Biopsy Test Volume and Forecast

4.3 United States - Lung Cancer Biopsy Test Market and Volume Forecast
4.3.1 United States - Lung Cancer Biopsy Test Market and Forecast
4.3.2 United States - Lung Cancer Biopsy Test Volume and Forecast

4.4 United States - Liver Cancer Biopsy Test Market and Volume Forecast
4.4.1 United States - Liver Cancer Biopsy Test Market and Forecast
4.4.2 United States - Liver Cancer Biopsy Test Volume and Forecast

4.5 United States - Thyroid Cancer Biopsy Test Market and Volume Forecast
4.5.1 United States - Thyroid Cancer Biopsy Test Market and Forecast
4.5.2 United States - Thyroid Cancer Biopsy Test Volume and Forecast

5. United States Biopsy Test Market - Growth Drivers
5.1 Inadequate Screening Tests for Particular Cancers
5.2 Demand for Minimally-Invasive Biopsy Techniques
5.3 Advancement in Biopsy Techniques
5.3.1 Advances in Prostate Biopsy Techniques
5.3.2 Advances in Breast Biopsy Techniques
5.3.3 Advances in Lung Biopsy Techniques
5.3.4 Advances in Liver Biopsy Techniques
5.3.5 Advances in Thyroid Biopsy Techniques

6. United States Biopsy Test Market - Challenges
6.1 Breast Biopsy Reimbursement Bundling
6.2 Biopsy Limitations



List of Figures:

Figure 2-1: United States - Biopsy Test Market (Million US$), 2008 - 2014
Figure 2-2: United States - Forecast for Biopsy Test Market (Million US$), 2015 - 2020
Figure 2-3: United States - Biopsy Test Volume (Thousand), 2008 - 2014
Figure 2-4: United States - Forecast for Biopsy Test Volume (Thousand), 2015 - 2020

Figure 3-1: United States - Biopsy Test Market Share (Percent), 2008 - 2014
Figure 3-2: United States - Forecast for Biopsy Test Market Share (Percent), 2015 - 2020
Figure 3-3: United States - Biopsy Test Volume Share (Percent), 2008 - 2014
Figure 3-4: United States - Forecast for Biopsy Test Volume Share (Percent), 2015 - 2020

Figure 4-1: United States - Prostate Cancer Biopsy Test Market (Million US$), 2008 - 2014
Figure 4-2: United States - Forecast for Prostate Cancer Biopsy Test Market (Million US$), 2015 -2020
Figure 4-3: United States - Prostate Cancer Biopsy Test Volume (Thousand), 2008 - 2014
Figure 4-4: United States - Forecast for Prostate Cancer Biopsy Test Volume (Thousand), 2015 - 2020
Figure 4-5: United States - Breast Cancer Biopsy Test Market (Million US$), 2008 - 2014
Figure 4-6: United States - Forecast for Breast Cancer Biopsy Test Market (Million US$), 2015 - 2020
Figure 4-7: United States - Breast Cancer Biopsy Test Volume (Thousand), 2008 - 2014
Figure 4-8: United States - Forecast for Breast Cancer Biopsy Test Volume (Thousand), 2015 - 2020
Figure 4-9: United States - Lung Cancer Biopsy Test Market (Million US$), 2008 - 2014
Figure 4-10: United States - Forecast for Lung Cancer Biopsy Test Market (Million US$), 2015 - 2020
Figure 4-11: United States - Lung Cancer Biopsy Test Volume (Thousand), 2008 - 2014
Figure 4-12: United States - Forecast for Lung Cancer Biopsy Test Volume (Thousand), 2015 - 2020
Figure 4-13: United States - Liver Cancer Biopsy Test Market (Million US$), 2008 - 2014
Figure 4-14: United States - Forecast for Liver Cancer Biopsy Test Market (Million US$), 2015 - 2020
Figure 4-15: United States - Liver Cancer Biopsy Test Volume (Thousand), 2008 - 2014
Figure 4-16: United States - Forecast for Liver Cancer Biopsy Test Volume (Thousand), 2015 - 2020
Figure 4-17: United States - Thyroid Cancer Biopsy Test Market (Million US$), 2008 - 2014
Figure 4-18: United States - Forecast for Thyroid Cancer Biopsy Test Market (Million US$), 2015 -2020
Figure 4-19: United States - Thyroid Cancer Biopsy Test Volume (Thousand), 2008 - 2014
Figure 4-20: United States - Forecast for Thyroid Cancer Biopsy Test Volume (Thousand), 2015 -2020


List of Tables:

Table 6-1: Breast Biopsy - Final Medicare Physician Fee Schedule, 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin, Blood, Kidney, Prostate, Ovarian And Pancreatic Cancer) And Segment Forecasts, 2014

Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin, Blood, Kidney, Prostate, Ovarian And Pancreatic Cancer) And Segment Forecasts, 2014

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing ...

Liquid Biopsy - Global Market Outlook (2016-2022)

Liquid Biopsy - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Liquid Biopsy market is expected to grow from $0.63 billion in 2015 to reach $2.93 billion by 2022 with a CAGR of 24.6%. Increasing research & developments and ...

Global Fluid Biopsy Market - Growth, Trends, and Forecasts (2016 - 2021)

Global Fluid Biopsy Market - Growth, Trends, and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global fluid biopsy market is expected to account for USD XX billion in 2021 from USD XX billion in 2016, growing at a CAGR of XX%. The rapid development of fluid biopsy is set to revolutionize the ...


Download Unlimited Documents from Trusted Public Sources

The future of the Clinical Trial Industry in the US

  • January 2017
    2 pages
  • Clinical Trial  

    Genome Sequenci...  

    Biopsy  

  • United States  

View report >

Biopsy Industry in Europe and the Netherlands

  • December 2016
    14 pages
  • Biopsy  

  • Europe  

    Netherlands  

View report >

Biopsy Industry in the Netherlands

  • December 2016
    10 pages
  • Biopsy  

  • Netherlands  

View report >

Related Market Segments :

Biopsy
Cancer

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.